On October 26, 2023 the IVAN Users Group hosted a meeting on NMR in the World of Fragmented Drug Design. The panel was lead by Daneen Angwin-Kaerner of Loxo@Lilly, and presentations were done by Andrew Namanja of Abbvie Inc. and Ben Davis of Vernalis Research. NMR has evolved into a[…]
